InvestorsHub Logo
Followers 49
Posts 11664
Boards Moderated 0
Alias Born 06/15/2014

Re: Laurent Maldague post# 412969

Monday, 07/24/2023 6:42:12 PM

Monday, July 24, 2023 6:42:12 PM

Post# of 429202
Assume this is no reason to lie, Raf apparently got a reply from Amarin IR, while not explaining the reason for the Mitigate termination, said that it was not related to safety, efficacy or quality concerns.


"investor.relations@amarincorp.com
to Me & 1 more
Today, 1:37 PM
1h MITIGATE was an Investigator Initiated Trial conducted at Kaiser Permanente Northern California that studied
Amarin's product VASCEPA/VAZKEPA (icosapent ethyl). Investigator Initiated Trials, or ITs, are run by the
investigators who initiate them. Recently Amarin was notified by Kaiser Permanente that the trial had been terminated prior to analysis of the study data. The study was not terminated or stopped due to any safety, efficacy or quality concerns
related to VASCEPA/VAZKEPA (icosapent ethyl). Amarin will have no further comment on the MITIGATE study or the circumstances surrounding the study's
termination.
Thank you,
Amarin IR"

Further I noticed that today (I believe) Raf was posting on ST that "Mitigate was stolen" from us and that he believes it was fraud. Not really sure I understand exactly what he is implying. If anyone can elucidate, it would be appreciated.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News